Australia markets closed

Inovio Pharmaceuticals, Inc. (INO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
10.02+0.34 (+3.51%)
At close: 04:00PM EDT
10.16 +0.14 (+1.40%)
After hours: 07:43PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
14,311
46,329
71,144
250,728
Other short-term investments
130,983
206,669
330,171
160,915
Total cash
145,294
252,999
401,315
411,643
Net receivables
0
1,702
5,467
18,560
Other current assets
20.432
375.227
261.192
40,464
Total current assets
153,113
315,243
448,445
471,171
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
35,305
39,520
47,969
40,083
Accumulated depreciation
-20,852
-21,563
-18,944
-15,994
Net property, plant and equipment
14,453
17,956
29,024
24,089
Equity and other investments
2,780
2,007
3,907
4,895
Goodwill
0
10,513
10,513
10,513
Intangible assets
-
2,130
2,626
3,147
Other long-term assets
605.315
684.044
1,426
25,957
Total non-current assets
17,838
33,291
47,497
68,602
Total assets
170,951
348,533
495,941
539,772
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
16,771
-
-
-
Accounts payable
4,648
21,083
27,973
1,468
Accrued liabilities
8,798
57,844
14,433
17,201
Deferred revenues
-
0
21.628
46.628
Other current liabilities
109.407
2,563
4,597
7,533
Total current liabilities
42,570
96,868
65,742
41,706
Non-current liabilities
Long-term debt
-
16,615
14,960
18,656
Deferred tax liabilities
0
32.046
32.046
32.046
Deferred revenues
-
0
64.361
79.214
Other long-term liabilities
-
-
14.826
57.663
Total non-current liabilities
11,032
29,302
30,530
36,926
Total liabilities
53,602
126,171
96,272
78,632
Stockholders' equity
Common stock
22.792
21.09
217.382
186.851
Retained earnings
-1,622,965
-1,487,848
-1,209,856
-906,197
Accumulated other comprehensive income
-662.601
-698.741
-282.236
-256.15
Total stockholders' equity
117,349
222,363
399,669
461,141
Total liabilities and stockholders' equity
170,951
348,533
495,941
539,772